CR HOLDINGS_Providing professional financial news and data related to CR HOLDINGS, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

CR HOLDINGS (01911.HK): Indirect Wholly-Owned Subsidiary China Renaissance Pan Asia Acts as Sole Financial Adviser to AlphaPai's Series B Financing

Tags：

CR HOLDINGS 01911.HK Financial Adviser

2026-09-14

Finance
WEIHAI BANK (09677.HK): Completes Issue of RMB 500 Million 2026 Green Financial Bonds (First Tranche) at 1.65% Coupon
Finance
HENGRUI PHARMA (01276.HK): Marketing Application for Class 1 Innovative Drug SHR-2004 Injection Accepted by NMPA for VTE Prevention After Knee Replacement Surgery
Finance
PUBLIC FIN HOLD (00626.HK): Appoints Somerley Capital as Independent Financial Adviser for Public Bank's Privatisation Proposal by Scheme of Arrangement
Finance
KWAN YONG (09998.HK): Positive Profit Alert, Expects FY2026 Net Profit Attributable to Owners of About SGD 19.8 Million
Finance
YIDU TECH (02158.HK): Affiliate Yidu Cloud Wins Bid for Ageing and Health Innovation Translation Project of Xiangya Hospital's National Clinical Medical Research Centre
Finance
HX COLDCHAIN (01641.HK): Subscribes for RMB 20 Million Structured Deposit with Bank of Communications, Constituting a Discloseable Transaction
Finance
CMS (00867.HK): Innovative Drug CMS-D001, a Highly Selective TYK2 Inhibitor, Receives Drug Clinical Trial Approval Notice for Systemic Lupus Erythematosus Indication
Finance
HUANENG POWER (00902.HK): Completes Issue of RMB 2.5 Billion 2026 Twelfth Tranche Super Short-Term Commercial Paper at 1.32%
Finance
CHINA COAL (01898.HK): Feng Jianhua Ceases to Be Securities Affairs Representative Due to Work Reassignment
Finance
CSPC PHARMA (01093.HK): Phase I/II Data of SYS6010 Combined with Enlangsuba Monoclonal Antibody in Previously Untreated Driver-Gene-Negative Advanced NSCLC Presented as Oral Presentation at 2026 WCLC

Scan QR Code

Download App